%0 Journal Article
%T Melanoma as Subsequent Primary Malignancy in Hematologic Cancer Survivors-A Literature Review.
%A Halmágyi SR
%A Ungureanu L
%A Trufin II
%A Apostu AP
%A Șenilă SC
%J J Clin Med
%V 13
%N 15
%D 2024 Aug 1
%M 39124768
%F 4.964
%R 10.3390/jcm13154501
%X The occurrence of second primary malignancies is becoming increasingly important among cancer survivors. Melanoma, an aggressive neoplasm originating from the melanocytes, is responsible for most skin cancer-related deaths. This review aims to explore the risk of melanoma occurrence as a second primary cancer after the most common subtypes of hematologic neoplasia, a malignant disease originating from myeloid or lymphocytic cell lineages. Chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL) are among the most associated subtypes with melanoma development. We also discuss the underlying hypotheses that may explain the associations between these malignancies and the impact of melanoma on survival. The review emphasizes the importance of increasing awareness of melanoma risk in hematologic cancer survivors, as it can lead to prompt recognition, improved skin surveillance, and better survival outcomes.